Literature DB >> 24470470

Comparative analyses of a cystic fibrosis isolate of Bordetella bronchiseptica reveal differences in important pathogenic phenotypes.

Neelima Sukumar1, Tracy L Nicholson, Matt S Conover, Tridib Ganguly, Rajendar Deora.   

Abstract

Bordetella bronchiseptica is a Gram-negative bacterium that infects and causes disease in a wide variety of animals. B. bronchiseptica also infects humans, thereby demonstrating zoonotic transmission. An extensive characterization of human B. bronchiseptica isolates is needed to better understand the distinct genetic and phenotypic traits associated with these zoonotic transmission events. Using whole-genome transcriptome and CGH analysis, we report that a B. bronchiseptica cystic fibrosis isolate, T44625, contains a distinct genomic content of virulence-associated genes and differentially expresses these genes compared to the sequenced model laboratory strain RB50, a rabbit isolate. The differential gene expression pattern correlated with unique phenotypes exhibited by T44625, which included lower motility, increased aggregation, hyperbiofilm formation, and an increased in vitro capacity to adhere to respiratory epithelial cells. Using a mouse intranasal infection model, we found that although defective in establishing high bacterial burdens early during the infection process, T44625 persisted efficiently in the mouse nose. By documenting the unique genomic and phenotypic attributes of T44625, this report provides a blueprint for understanding the successful zoonotic potential of B. bronchiseptica and other zoonotic bacteria.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24470470      PMCID: PMC3993408          DOI: 10.1128/IAI.01453-13

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  65 in total

1.  Pneumonia due to Bordetella bronchiseptica in a cystic fibrosis patient: 16S rRNA sequencing for diagnosis confirmation.

Authors:  Frédéric Wallet; Thierry Perez; Sylvie Armand; Benoit Wallaert; René J Courcol
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

2.  Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica.

Authors:  Julian Parkhill; Mohammed Sebaihia; Andrew Preston; Lee D Murphy; Nicholas Thomson; David E Harris; Matthew T G Holden; Carol M Churcher; Stephen D Bentley; Karen L Mungall; Ana M Cerdeño-Tárraga; Louise Temple; Keith James; Barbara Harris; Michael A Quail; Mark Achtman; Rebecca Atkin; Steven Baker; David Basham; Nathalie Bason; Inna Cherevach; Tracey Chillingworth; Matthew Collins; Anne Cronin; Paul Davis; Jonathan Doggett; Theresa Feltwell; Arlette Goble; Nancy Hamlin; Heidi Hauser; Simon Holroyd; Kay Jagels; Sampsa Leather; Sharon Moule; Halina Norberczak; Susan O'Neil; Doug Ormond; Claire Price; Ester Rabbinowitsch; Simon Rutter; Mandy Sanders; David Saunders; Katherine Seeger; Sarah Sharp; Mark Simmonds; Jason Skelton; Robert Squares; Steven Squares; Kim Stevens; Louise Unwin; Sally Whitehead; Bart G Barrell; Duncan J Maskell
Journal:  Nat Genet       Date:  2003-08-10       Impact factor: 38.330

3.  Bordetella bronchiseptica peritonitis -- beware of the dog!

Authors:  K Hadley; A Montante Torres; J Moran; B Schiller
Journal:  Perit Dial Int       Date:  2009 Nov-Dec       Impact factor: 1.756

4.  A simple chemically defined medium for the production of phase I Bordetella pertussis.

Authors:  D W Stainer; M J Scholte
Journal:  J Gen Microbiol       Date:  1970-10

Review 5.  The changing microbial epidemiology in cystic fibrosis.

Authors:  John J Lipuma
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

6.  Identification and characterization of BipA, a Bordetella Bvg-intermediate phase protein.

Authors:  K E Stockbauer; B Fuchslocher; J F Miller; P A Cotter
Journal:  Mol Microbiol       Date:  2001-01       Impact factor: 3.501

Review 7.  Cystic fibrosis pathogenesis and the role of biofilms in persistent infection.

Authors:  J W Costerton
Journal:  Trends Microbiol       Date:  2001-02       Impact factor: 17.079

8.  Cyclic-di-GMP signalling regulates motility and biofilm formation in Bordetella bronchiseptica.

Authors:  Federico Sisti; Dae-Gon Ha; George A O'Toole; Daniela Hozbor; Julieta Fernández
Journal:  Microbiology       Date:  2013-03-08       Impact factor: 2.777

9.  The Bordetella Bps polysaccharide is critical for biofilm development in the mouse respiratory tract.

Authors:  Gina Parise Sloan; Cheraton F Love; Neelima Sukumar; Meenu Mishra; Rajendar Deora
Journal:  J Bacteriol       Date:  2007-06-22       Impact factor: 3.490

10.  Identification of Bordetella spp. in respiratory specimens from individuals with cystic fibrosis.

Authors:  T Spilker; A A Liwienski; J J LiPuma
Journal:  Clin Microbiol Infect       Date:  2008-03-04       Impact factor: 8.067

View more
  12 in total

1.  Hyperbiofilm Formation by Bordetella pertussis Strains Correlates with Enhanced Virulence Traits.

Authors:  Natalia Cattelan; Jamie Jennings-Gee; Purnima Dubey; Osvaldo M Yantorno; Rajendar Deora
Journal:  Infect Immun       Date:  2017-11-17       Impact factor: 3.441

2.  Bordetella Colonization Factor A (BcfA) Elicits Protective Immunity against Bordetella bronchiseptica in the Absence of an Additional Adjuvant.

Authors:  Kacy S Yount; Jamie Jennings-Gee; Kyle Caution; Audra R Fullen; Kara N Corps; Sally Quataert; Rajendar Deora; Purnima Dubey
Journal:  Infect Immun       Date:  2019-09-19       Impact factor: 3.441

3.  The protein BpsB is a poly-β-1,6-N-acetyl-D-glucosamine deacetylase required for biofilm formation in Bordetella bronchiseptica.

Authors:  Dustin J Little; Sonja Milek; Natalie C Bamford; Tridib Ganguly; Benjamin R DiFrancesco; Mark Nitz; Rajendar Deora; P Lynne Howell
Journal:  J Biol Chem       Date:  2015-07-22       Impact factor: 5.157

4.  The Transcriptional Regulator BpsR Controls the Growth of Bordetella bronchiseptica by Repressing Genes Involved in Nicotinic Acid Degradation.

Authors:  Manita Guragain; Jamie Jennings-Gee; Natalia Cattelan; Mary Finger; Matt S Conover; Thomas Hollis; Rajendar Deora
Journal:  J Bacteriol       Date:  2018-05-24       Impact factor: 3.490

Review 5.  Bordetella biofilms: a lifestyle leading to persistent infections.

Authors:  Natalia Cattelan; Purnima Dubey; Laura Arnal; Osvaldo M Yantorno; Rajendar Deora
Journal:  Pathog Dis       Date:  2015-11-19       Impact factor: 3.166

6.  Draft Genome Assembly of Bordetella bronchiseptica ATCC 10580, a Historical Canine Clinical Isolate.

Authors:  H E Daligault; K W Davenport; T D Minogue; K A Bishop-Lilly; D C Bruce; P S Chain; S R Coyne; K G Frey; J Jaissle; G I Koroleva; J T Ladner; C-C Lo; L Meincke; C Munk; G F Palacios; C L Redden; S L Johnson
Journal:  Genome Announc       Date:  2014-09-18

7.  PgaB orthologues contain a glycoside hydrolase domain that cleaves deacetylated poly-β(1,6)-N-acetylglucosamine and can disrupt bacterial biofilms.

Authors:  Dustin J Little; Roland Pfoh; François Le Mauff; Natalie C Bamford; Christina Notte; Perrin Baker; Manita Guragain; Howard Robinson; Gerald B Pier; Mark Nitz; Rajendar Deora; Donald C Sheppard; P Lynne Howell
Journal:  PLoS Pathog       Date:  2018-04-23       Impact factor: 6.823

8.  Bordetella pertussis Can Be Motile and Express Flagellum-Like Structures.

Authors:  Casandra L Hoffman; Laura A Gonyar; Federico Zacca; Federico Sisti; Julieta Fernandez; Ting Wong; F Heath Damron; Erik L Hewlett
Journal:  mBio       Date:  2019-05-14       Impact factor: 7.786

9.  Cystic Fibrosis Mice Develop Spontaneous Chronic Bordetella Airway Infections.

Authors:  R Darrah; T Bonfield; J J LiPuma; P Litman; C A Hodges; F Jacono; M Drumm
Journal:  J Infect Pulm Dis       Date:  2017-11-02

10.  Blood or Serum Exposure Induce Global Transcriptional Changes, Altered Antigenic Profile, and Increased Cytotoxicity by Classical Bordetellae.

Authors:  Monica C Gestal; Israel Rivera; Laura K Howard; Kalyan K Dewan; Illiassou Hamidou Soumana; Margaret Dedloff; Tracy L Nicholson; Bodo Linz; Eric T Harvill
Journal:  Front Microbiol       Date:  2018-09-07       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.